Nevertheless, because the signaling pathways identified in these preclinical studies are also implicated in the pathogenesis of human heart failure, these pre-clinical findings provide a strong rationale for future clinical and translational research to clarify the underlying mechanisms and evaluate the therapeutic potential of sGC stimulators in this setting. The gene discussed is SGCB; the disease is heart failure.